StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.78+0.03 (+1.09%)

Close on Nov 17, 2026Market cap $26.02MP/E –Yield –

Adicet Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Adicet Bio's operating income for the twelve months ending Jun 30, 2026 was -$103.71M. For fiscal 2025 it was -$122.11M. The highest annual figure on record is -$14.96M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$122.11M–
FY2024Dec 31, 2024-$127.62M–
FY2023Dec 31, 2023-$152.04M–
FY2022Dec 31, 2022-$72.55M–
FY2021Dec 31, 2021-$61.43M–
FY2020Dec 31, 2020-$39.19M–
FY2019Dec 31, 2019-$31.39M–
FY2018Dec 31, 2018-$14.96M–
FY2017Dec 31, 2017-$18.88M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.30M–
Q1 FY2026Mar 31, 2026-$21.57M–
Q4 FY2025Dec 31, 2025-$31.89M–
Q3 FY2025Sep 30, 2025-$27.95M–
Q2 FY2025Jun 30, 2025-$32.39M–
Q1 FY2025Mar 31, 2025-$29.89M–
Q4 FY2024Dec 31, 2024-$30.74M–
Q3 FY2024Sep 30, 2024-$33.15M–
Q2 FY2024Jun 30, 2024-$32.85M–
Q1 FY2024Mar 31, 2024-$30.87M–
Q4 FY2023Dec 31, 2023-$31.57M–
Q3 FY2023Sep 30, 2023-$52.26M–
Q2 FY2023Jun 30, 2023-$34.89M–
Q1 FY2023Mar 31, 2023-$33.32M-808.1%
Q4 FY2022Dec 31, 2022-$31.57M–
Q3 FY2022Sep 30, 2022-$22.99M–
Q2 FY2022Jun 30, 2022-$22.71M–
Q1 FY2022Mar 31, 2022$4.71M–
Q4 FY2021Dec 31, 2021-$15.54M–
Q3 FY2021Sep 30, 2021-$13.71M–
Q2 FY2021Jun 30, 2021-$10.83M–
Q1 FY2021Mar 31, 2021-$21.35M–
Q4 FY2020Dec 31, 2020-$9.35M–
Q3 FY2020Sep 30, 2020-$13.66M–
Q2 FY2020Jun 30, 2020-$8.63M–
Q1 FY2020Mar 31, 2020-$7.56M–
Q4 FY2019Dec 31, 2019-$29.44M–
Q3 FY2019Sep 30, 2019-$15.23M–
Q2 FY2019Jun 30, 2019-$19.17M–
Q1 FY2019Mar 31, 2019-$11.69M–
Q4 FY2018Dec 31, 2018-$6.36M–
Q3 FY2018Sep 30, 2018-$9.03M–
Q2 FY2018Jun 30, 2018-$14.11M–
Q1 FY2018Mar 31, 2018-$10.20M–
Q4 FY2017Dec 31, 2017-$7.52M–
Q3 FY2017Sep 30, 2017-$3.95M–
Q2 FY2017Jun 30, 2017-$4.06M–
Q1 FY2017Mar 31, 2017-$3.36M–

More Adicet Bio figures

See a number that looks wrong?